Technetium-99m Radiopharmaceuticals: Status and Trends

IAEA Radioisotopes and Radiopharmaceuticals Series No. 1

Subject Classification: 0101-Nuclear medicine (including radiopharmaceuticals)

English STI/PUB/1405; (ISBN:978-92-0-103509-7); 360 pp.; 115 figures; € 52.00; Date Published: 2010

Download PDF (5.27 MB)

Technetium-99m radiopharmaceuticals will continue to have a significant impact in several areas of nuclear medicine. This publication is intended to provide a broad overview of the current status of technetium-99m radiopharmaceuticals. It includes chapters on the most advanced chemical techniques for labelling biomolecules and synthesizing suitable multifunctional ligands that will help in the development of specific radiotracers. Of special interest for the reader are details of recent research to develop technetium-99m tracers for monitoring different biological processes enabling the development of new radiopharmaceuticals with greatly improved clinical potential.

Download Order Form PDF
You might also like

Cyclotron Produced Radionuclides: Emerging Positron Emitters for Medical Applications: 64Cu and 124I ...

Read more

Good Practice for Introducing Radiopharmaceuticals for Clinical Use ...

Read more

Quality Management Audits in Nuclear Medicine Practices ...

Read more

Radiopharmaceuticals for Sentinel Lymph Node Detection: Status and Trends ...

Read more

Yttrium-90 and Rhenium-188 Radiopharmaceuticals for Radionuclide Therapy ...

Read more

IAEA Syllabus for the Education and Training of Radiation Oncologists ...

Read more

IAEA Syllabus for the Education and Training of Radiation Oncologists ...

Read more

IAEA Syllabus for the Education and Training of Radiation Oncologists ...

Read more

Quantitative Nuclear Medicine Imaging: Concepts, Requirements and Methods ...

Read more

IAEA Syllabus for the Education and Training of Radiation Oncologists ...

Read more

Standard Operating Procedures for PET/CT: A Practical Approach for Use in Adult Oncology ...

Read more

Practical Guidance on Peptide Receptor Radionuclide Therapy (PRRNT) for Neuroendocrine Tumours ...

Read more

Cyclotron Produced Radionuclides: Operation and Maintenance of Gas and Liquid Targets ...

Read more

Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of Fluorodeoxyglucose (FDG) ...

Read more

Production of Long Lived Parent Radionuclides for Generators: 68Ge, 82Sr, 90Sr and 188W ...

Read more